Sort
46,585 grants matching “heart failure”
Individualizing Therapy for Kidney and Heart Transplant Recipients
$2,391,622Peter Scott Heeger · Icahn School Of Medicine At Mount Sinai · U01 · FY2010 · AI
Combined Cardiopulmonary Failure in COPD: SPIROMICS HF
$2,391,491R Graham Barr · Columbia University Health Sciences · R01 · FY2019 · HL
BIOMEDICAL (BASIC)
$2,389,813Jackson Wright · Case Western Reserve University · N01 · FY2013 · HL
Integrated Mechanisms of Cardiac Maladaptation
$2,389,679R John Solaro · University Of Illinois At Chicago · P01 · FY2009 · HL
Mechanisms that Govern Cardiomyocyte Proliferation and Remuscularization following Ventricular Injury
$2,387,932Jianyi Zhang · University Of Alabama At Birmingham · P01 · FY2022 · HL
ARIC Neurocognitive Study
$2,386,880Thomas H Mosley · University Of Mississippi Med Ctr · U01 · FY2011 · HL
Multi-organ human-on-a-chip system to address overdose and acute and chronic efficacy and off-target toxicity
$2,381,424James J Hickman · University Of Central Florida · UH3 · FY2021 · TR
Elucidating Electro-Mechanical Dysfunction in Heart Failure with Human Stem Cell Models
$2,380,225Joseph C Wu · Stanford University · P01 · FY2019 · HL
Metabolic and epigenetic reprogramming of vital organs in SARS-CoV-2 induced systemic toxicity
$2,378,661Arjun Deb · University Of California Los Angeles · R01 · FY2023 · DK
Brain Tumor SPORE Grant
$2,375,000Mitchel S. Berger · University Of California, San Francisco · P50 · FY2020 · CA
Molecular Transducers of Physical Activity and Health: NC Consortium Clinical Site
$2,375,000William E Kraus · Duke University · U01 · FY2021 · AR
Molecular Transducers of Physical Activity and Health: NC Consortium Clinical Site
$2,375,000William E Kraus · Duke University · U01 · FY2022 · AR
CLINICAL EXAMINATION CENTER
$2,374,518Josef Coresh · Johns Hopkins University · N01 · FY2012 · HL
Gulf South STI/Topical Microbicide Cooperative Research Center
$2,374,443David H. Martin · Lsu Health Sciences Center · U19 · FY2008 · AI
Center of Biomedical Research Excellence in Cardiovascular Health
$2,374,059David G Edwards · University Of Delaware · P20 · FY2024 · GM
CaMKII and IP3-Mediated Signaling in Cardiac Myocytes
$2,372,958Donald M Bers · University Of California At Davis · P01 · FY2009 · HL
PREVENTABLE Trial Implementation Phase
$2,372,685Karen P Alexander · Duke University · U19 · FY2022 · AG
Systolic Blood Pressure Intervention Trial (SPRINT)
$2,370,640National Heart, Lung, And Blood Institute · Y01 · FY2016 · HL
Uncovering New Roles for Mechanical Force in Tissue Development and Remodeling
$2,370,000Alexander R Dunn · Stanford University · DP2 · FY2010 · OD
IVEM and Image Analysis Resource
$2,368,554Mark H Ellisman · University Of California, San Diego · P41 · FY2012 · GM
Individualizing Therapy for Kidney and Heart Transplant Recipients
$2,367,532Peter Scott Heeger · Icahn School Of Medicine At Mount Sinai · U01 · FY2011 · AI
Glycoconjugates and Cardiovascular Disease
$2,366,191Gerald Warren Hart · Johns Hopkins University · P01 · FY2013 · HL
Elucidating Electro-Mechanical Dysfunction in Heart Failure with Human Stem Cell Models
$2,366,100Joseph C Wu · Stanford University · P01 · FY2020 · HL
Elucidating Electro-Mechanical Dysfunction in Heart Failure with Human Stem Cell Models
$2,366,100Joseph C Wu · Stanford University · P01 · FY2021 · HL
Elucidating Electro-Mechanical Dysfunction in Heart Failure with Human Stem Cell Models
$2,366,100Joseph C Wu · Stanford University · P01 · FY2022 · HL